Select Publications
Conference Abstracts
2019, 'PS920 PHF6 LOSS DRIVES IL7R ONCOGENE ADDICTION IN TLX1 DRIVEN T‐ALL', in HemaSphere, Wiley, Vol. 3, pp. 414 - 415, http://dx.doi.org/10.1097/01.hs9.0000561956.76629.c7
,2019, 'S858 SUZ12 INACTIVATION COOPERATES WITH JAK3 MUTANT SIGNALING TO DRIVE T‐ALL DEVELOPMENT', in HemaSphere, Wiley, Vol. 3, pp. 383 - 384, http://dx.doi.org/10.1097/01.hs9.0000561712.29231.fb
,Working Papers
2021, Optimized Flow Cytometric Detection of Transient Receptor Potential Vanilloid-1 (TRPV1) in Human Hematological Malignancies, medRxiv, http://dx.doi.org10.1101/2021.08.04.21261521
,Preprints
2024, PU.1 Eviction at Lymphocyte-Specific Chromatin Domains Mediates Glucocorticoid Response in Acute Lymphoblastic Leukemia, , http://dx.doi.org/10.21203/rs.3.rs-3872306/v1
,2023, The tumour suppressor Fat1 is dispensable for normal murine hematopoiesis, , http://dx.doi.org/10.1101/2023.12.20.572284
,2022, Blockade of redox second messengers inhibits JAK/STAT and MEK/ERK signaling sensitizing FLT3-mutant acute myeloid leukemia to targeted therapies, , http://dx.doi.org/10.1101/2022.03.09.483687
,Other
2023, Data from The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia, , http://dx.doi.org/10.1158/1078-0432.c.6529397
,2023, Data from The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia, , http://dx.doi.org/10.1158/1078-0432.c.6529397.v1
,2023, Supplement from The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia, , http://dx.doi.org/10.1158/1078-0432.22476449
,2023, Supplement from The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia, , http://dx.doi.org/10.1158/1078-0432.22476449.v1
,2023, Supplementary Figure 1 from The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia, , http://dx.doi.org/10.1158/1078-0432.22476443
,2023, Supplementary Figure 1 from The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia, , http://dx.doi.org/10.1158/1078-0432.22476443.v1
,2023, Supplementary Figure 2 from The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia, , http://dx.doi.org/10.1158/1078-0432.22476440.v1
,2023, Supplementary Figure 2 from The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia, , http://dx.doi.org/10.1158/1078-0432.22476440
,2023, Supplementary Figure 3 from The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia, , http://dx.doi.org/10.1158/1078-0432.22476437
,2023, Supplementary Figure 3 from The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia, , http://dx.doi.org/10.1158/1078-0432.22476437.v1
,2023, Supplementary Figure 4 from The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia, , http://dx.doi.org/10.1158/1078-0432.22476434.v1
,2023, Supplementary Figure 4 from The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia, , http://dx.doi.org/10.1158/1078-0432.22476434
,2023, Supplementary Table 4 from The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia, , http://dx.doi.org/10.1158/1078-0432.22476431
,2023, Supplementary Table 4 from The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia, , http://dx.doi.org/10.1158/1078-0432.22476431.v1
,2023, Supplementary Table 5 from The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia, , http://dx.doi.org/10.1158/1078-0432.22476428.v1
,2023, Supplementary Table 5 from The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia, , http://dx.doi.org/10.1158/1078-0432.22476428
,2016, Measures of success, AMER ASSOC ADVANCEMENT SCIENCE, , https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000373039600017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, Measures of success Reply, AMER ASSOC ADVANCEMENT SCIENCE, , https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000373039600052&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,